Nine Months 2019 Verona Pharma PLC Earnings Call Transcript
Hello, ladies and gentlemen, and welcome to the Verona Pharma Third Quarter 2019 Conference Call. (Operator Instructions) As a reminder, this call is being recorded.
I would now like to turn the call over to Ms. Kimberly Minarovich, Managing Director, Argot Partners.
Thank you, Lisa. Good morning or afternoon, depending on which time zone you are in, and welcome to today's call to review Verona Pharma's results for the 3 and 9 months ended September 30, 2019. With me today is Jan-Anders Karlsson, Chief Executive Officer, and Piers Morgan, Chief Financial Officer.
Earlier this morning we issued a press release detailing these financial results as well as clinical developments. A copy of the release can be found in the Investor Relations tab on the corporate website www.veronapharma.com.
On today's call, Jan-Anders will first provide an update on the clinical development of the company's lead candidate, ensifentrine.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
